UNSPSC 51373333: Belladonna/opium

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class CN101. This VA Drug Class (CN101) classifies this compound as belonging to the group OPIOID ANALGESICS.

UNSPSC 51373333 Belladonna/opium, a Commodity code, sees minimal state and local procurement activity aligned with its nominal pharmaceutical scope. The single recent opportunity on record—Seminole County, Florida's IFB 60459723LAS—solicits naloxone and safe drug deactivation systems rather than belladonna or opium derivatives, indicating a substantial mismatch between the code's taxonomy label and the work actually being bought. State and local governments appear to use this code infrequently or misclassify opioid-related procurements under it; the Seminole County bid represents a public-health intervention (naloxone distribution and drug disposal) rather than sourcing of controlled pharmaceutical precursors or opioid compounds.

Seminole County's June 2026 posting sought 1,900 units of naloxone and 800 safe drug deactivation systems annually, with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The IFB required electronic submission through the county's e-Procurement Portal by July 26, 2023, included E-Verify and drug-free workplace compliance, and offered an initial two-year term with a one-year renewal option. The procurement was potentially funded through FEMA and subject to federal environmental compliance. Beyond this single Seminole County opportunity, the code shows no identifiable recent state and local activity; business development professionals should treat this code as dormant for procurement purposes and verify any opportunities tagged under it against their actual scope before pursuing.